Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists, inhibitors |
Mechanism A1R antagonists(Adenosine A1 receptor antagonists), A2aR antagonists(Adenosine A2a receptor antagonists), COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (14 Jan 1998), |
Regulation- |
Molecular FormulaC8H10N4O2 |
InChIKeyRYYVLZVUVIJVGH-UHFFFAOYSA-N |
CAS Registry58-08-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Migraine Disorders | United States | 14 Jan 1998 | |
Anesthesia | China | - | - |
Phase 4 | 93 | (Aspirin, Acetaminophen, Caffeine Pills) | iuucafrtgg(qlymxeftdl) = eeokeikflm ifnkspping (pdyafolavi, vxklhjipal - xprtduhnry) View more | - | 18 Mar 2020 | ||
(Prochlorperazine 10mg) | iuucafrtgg(qlymxeftdl) = mccskanznv ifnkspping (pdyafolavi, pmsjsgzmir - fudzfxlpxl) View more |